EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

NeuO-mediated O-acetylation of uropathogenic Escherichia coli K1 capsule enhances resistance to phage and neutrophil killing

Lachlan L Walker, Nguyen Thi Khanh Nhu iD, Zheng Jie Lian, Kate M Peters, Mercedes Monteleone, James P R Connolly, Mark J Walker iD, Brian M Forde iD, Kate Schroder iD, Matthew J Sweet iD, Minh-Duy Phan iD, Mark A Schembri iD

Journal of Bacteriology · 2026

DOI: 10.1128/jb.00610-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Bacteriology, 2026. Verfasst von Lachlan L Walker und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia. Hauptthemen laut MEDLINE: Uropathogenic Escherichia coli, Bacterial Capsules, Neutrophils, Acetyltransferases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Uropathogenic Escherichia coli (UPEC) strains that express the K1 capsule are associated with severe invasive disease, including pyelonephritis, urosepsis, and neonatal meningitis. The K1 capsule can be modified by NeuO, a phage-encoded phase-variable O-acetyltransferase. The role of O-acetylation in pathogenesis of K1 UPEC remains to be fully elucidated. Here, we assessed the prevalence of the neuO gene in a K1 E. coli data set comprising 8,659 genomes and observed that 43.5% of genomes harbor neuO , with a high prevalence (88.1%) in the pandemic UPEC clone sequence type (ST) 95. We generated an isogenic ∆ neuO mutant in the reference ST95 strain MS7163 and complemented this with a phase-ON locked version of the neuO gene, resulting in constitutive O-acetylation of the K1 capsule. The phase-variable rate of neuO in MS7163 was measured by fragment analysis at 93% phase-ON with 21 heptanucleotide repeats. NeuO acetylated the K1 sialic acid into O-acetylated forms, including Neu5,7Ac2, Neu5,8Ac2, and Neu5,9Ac2. We demonstrate that O-acetylation increased survival of K1 UPEC to lytic K1 phage and human neutrophils, yet increased susceptibility to human serum. O-acetylation of the K1 capsule did not influence bladder colonization in a murine model of urinary tract infection. Overall, we hypothesize that phase-variable O-acetylation is a niche-specific adaptive mechanism that enhances survival of UPEC in different ways, including protection against K1 phage and resistance to neutrophil-mediated killing. IMPORTANCE The K1 polysialic acid capsule is a key virulence factor of uropathogenic Escherichia coli (UPEC). A subset of K1 UPEC possesses the phage-encoded phase-variable neuO gene, which mediates O-acetylation of the capsule. However, the prevalence, phase dynamics, and biological consequences of this modification remain to be fully elucidated. Here, we show that the neuO gene exhibits variable distribution among K1 UPEC, with a high prevalence in the global ST95 clone and evidence for active phase switching. We further demonstrate that K1 O-acetylation confers resistance to phage and neutrophil killing, suggesting a role associated with enhanced survival in infection and environmental settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uropathogenic Escherichia coliBacterial CapsulesNeutrophilsAcetyltransferasesEscherichia coli ProteinsAcetylationAnimalsMiceEscherichia coli InfectionsHumansFemaleUrinary Tract InfectionsDisease Models, AnimalAntigens, BacterialPolysaccharides, Bacterial

Stichwörter der Autor:innen

bacterial pathogenesisbacterial virulencecapsulephase variationurinary tract infectionuropathogenic Escherichia coli

Substanzen

capsular polysaccharide K1AcetyltransferasesEscherichia coli ProteinsAntigens, BacterialPolysaccharides, Bacterial

Autor:innen und Institutionen

  • Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia.
  • Australian Infectious Diseases Research Centre, The University of Queensland, Brisbane, Queensland, Australia.
  • Newcastle University Biosciences Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • UQ Centre for Clinical Research, Faculty of Health and Behavioural Sciences, The University of Queensland, Brisbane, Queensland, Australia.
  • School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Queensland, Australia.

ORCID-Profile: Nguyen Thi Khanh Nhu, Mark J Walker, Brian M Forde, Kate Schroder, Matthew J Sweet, Minh-Duy Phan, Mark A Schembri

Zitieren

APA

Walker, L. L., Nhu, N. T. K., Lian, Z. J., Peters, K. M., Monteleone, M., Connolly, J. P. R., Walker, M. J., Forde, B. M., Schroder, K., Sweet, M. J., Phan, M. D., & Schembri, M. A. (2026). NeuO-mediated O-acetylation of uropathogenic Escherichia coli K1 capsule enhances resistance to phage and neutrophil killing. Journal of Bacteriology. https://doi.org/10.1128/jb.00610-25

Vancouver

Walker LL, Nhu NTK, Lian ZJ, Peters KM, Monteleone M, Connolly JPR, et al. NeuO-mediated O-acetylation of uropathogenic Escherichia coli K1 capsule enhances resistance to phage and neutrophil killing. Journal of Bacteriology. 2026. doi:10.1128/jb.00610-25

BibTeX
@article{Walker2026,
  author = {Walker, Lachlan L and Nhu, Nguyen Thi Khanh and Lian, Zheng Jie and Peters, Kate M and Monteleone, Mercedes and Connolly, James P R and Walker, Mark J and Forde, Brian M and Schroder, Kate and Sweet, Matthew J and Phan, Minh-Duy and Schembri, Mark A},
  title = {NeuO-mediated O-acetylation of uropathogenic Escherichia coli K1 capsule enhances resistance to phage and neutrophil killing},
  journal = {Journal of Bacteriology},
  year = {2026},
  doi = {10.1128/jb.00610-25}
}
Kostenlos starten →